Vicky A. Blakesley

1.9k total citations
29 papers, 1.5k citations indexed

About

Vicky A. Blakesley is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Vicky A. Blakesley has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Vicky A. Blakesley's work include Growth Hormone and Insulin-like Growth Factors (18 papers), Metabolism, Diabetes, and Cancer (15 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Vicky A. Blakesley is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (18 papers), Metabolism, Diabetes, and Cancer (15 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Vicky A. Blakesley collaborates with scholars based in United States, United Kingdom and Chile. Vicky A. Blakesley's co-authors include Derek LeRoith, Bethel Stannard, Derek Le Roith, Angus G. Scrimgeour, Thea Kalebic, Lee J. Helman, Derek LeRoith, Diana L. Esposito, Robert I. Berkowitz and Derek LeRoith and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Internal Medicine and American Journal of Psychiatry.

In The Last Decade

Vicky A. Blakesley

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicky A. Blakesley United States 24 812 612 179 164 163 29 1.5k
A. Mancini Italy 25 407 0.5× 384 0.6× 127 0.7× 146 0.9× 165 1.0× 73 1.5k
L. Morgan United Kingdom 23 704 0.9× 399 0.7× 193 1.1× 163 1.0× 369 2.3× 40 2.1k
A. Traish United States 25 463 0.6× 914 1.5× 57 0.3× 114 0.7× 153 0.9× 35 1.8k
J.H.H. Thijssen Netherlands 24 381 0.5× 806 1.3× 140 0.8× 173 1.1× 198 1.2× 86 2.1k
Léonello Cusan Canada 30 475 0.6× 1.7k 2.9× 173 1.0× 257 1.6× 73 0.4× 42 3.2k
José‐Luis Gomez Canada 24 393 0.5× 1.4k 2.3× 154 0.9× 244 1.5× 88 0.5× 27 2.9k
Fuquan Wu China 16 638 0.8× 162 0.3× 330 1.8× 117 0.7× 103 0.6× 22 1.7k
J Gustafsson Sweden 27 1.1k 1.3× 575 0.9× 231 1.3× 117 0.7× 149 0.9× 53 2.8k
Giorgio Napolitano Italy 24 395 0.5× 625 1.0× 140 0.8× 156 1.0× 263 1.6× 88 1.8k

Countries citing papers authored by Vicky A. Blakesley

Since Specialization
Citations

This map shows the geographic impact of Vicky A. Blakesley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky A. Blakesley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky A. Blakesley more than expected).

Fields of papers citing papers by Vicky A. Blakesley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky A. Blakesley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky A. Blakesley. The network helps show where Vicky A. Blakesley may publish in the future.

Co-authorship network of co-authors of Vicky A. Blakesley

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky A. Blakesley. A scholar is included among the top collaborators of Vicky A. Blakesley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky A. Blakesley. Vicky A. Blakesley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Apovian, Caroline M., Louis J. Aronne, Madelyn H. Fernstrom, et al.. (2007). Sibutramine Plus Meal Replacement Therapy for Body Weight Loss and Maintenance in Obese Patients. Obesity. 15(6). 1464–1472. 21 indexed citations
2.
Blakesley, Vicky A.. (2005). Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate. The AAPS Journal. 7(1). E42–E46. 25 indexed citations
3.
Blakesley, Vicky A., Walid M. Awni, Charles Locke, et al.. (2004). Are Bioequivalence Studies of Levothyroxine Sodium Formulations in Euthyroid Volunteers Reliable?. Thyroid. 14(3). 191–200. 61 indexed citations
4.
5.
Kalebic, Thea, et al.. (1998). Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-R. International Journal of Cancer. 76(2). 223–227. 45 indexed citations
6.
Okubo, Yumiko, Vicky A. Blakesley, Bethel Stannard, J. Silvio Gutkind, & Derek Le Roith. (1998). Insulin-like Growth Factor-I Inhibits the Stress-activated Protein Kinase/c-Jun N-terminal Kinase. Journal of Biological Chemistry. 273(40). 25961–25966. 73 indexed citations
7.
Párrizas, Marcelina, Vicky A. Blakesley, Dana Beitner‐Johnson, & Derek Le Roith. (1997). The Proto-oncogene Crk-II Enhances Apoptosis by a Ras-Dependent, Raf-1/MAP Kinase-Independent Pathway. Biochemical and Biophysical Research Communications. 234(3). 616–620. 18 indexed citations
8.
Liu, Jun‐Li, Vicky A. Blakesley, J. Silvio Gutkind, & Derek LeRoith. (1997). The Constitutively Active Mutant Gα13Transforms Mouse Fibroblast Cells Deficient in Insulin-like Growth Factor-I Receptor. Journal of Biological Chemistry. 272(47). 29438–29441. 30 indexed citations
9.
Foncea, Rocı́o, Monica Andersson, Albert J. Ketterman, et al.. (1997). Insulin-like Growth Factor-I Rapidly Activates Multiple Signal Transduction Pathways in Cultured Rat Cardiac Myocytes. Journal of Biological Chemistry. 272(31). 19115–19124. 172 indexed citations
10.
Butler, Andrew A., et al.. (1997). In Vivo Regulation of CrkII and CrkL Proto-oncogenes in the Uterus by Insulin-like Growth Factor-I. Journal of Biological Chemistry. 272(44). 27660–27664. 26 indexed citations
11.
Blakesley, Vicky A., Dana Beitner‐Johnson, James R. Van Brocklyn, et al.. (1997). Sphingosine 1-Phosphate Stimulates Tyrosine Phosphorylation of Crk. Journal of Biological Chemistry. 272(26). 16211–16215. 33 indexed citations
12.
Blakesley, Vicky A., Bethel Stannard, Thea Kalebic, Lee J. Helman, & Derek LeRoith. (1997). Role of the IGF-I receptor in mutagenesis and tumor promotion. Journal of Endocrinology. 152(3). 339–344. 64 indexed citations
13.
14.
Roith, Derek Le, Marcelina Párrizas, & Vicky A. Blakesley. (1997). The insulin-like growth factor-I receptor and apoptosis. Endocrine. 7(1). 103–105. 23 indexed citations
15.
16.
17.
Beitner‐Johnson, Dana, Vicky A. Blakesley, Zila Shen‐Orr, et al.. (1996). The Proto-oncogene Product c-Crk Associates with Insulin Receptor Substrate-1 and 4PS. Journal of Biological Chemistry. 271(16). 9287–9290. 69 indexed citations
18.
Blakesley, Vicky A., Angus G. Scrimgeour, Diana L. Esposito, & Derek Le Roith. (1996). Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling?. Cytokine & Growth Factor Reviews. 7(2). 153–159. 139 indexed citations
19.
Blakesley, Vicky A., H. Kato, Charles T. Roberts, & Derek LeRoith. (1995). Mutation of a Conserved Amino Acid Residue (Tryptophan 1173) in the Tyrosine Kinase Domain of the IGF-I Receptor Abolishes Autophosphorylation but Does Not Eliminate Biologic Function. Journal of Biological Chemistry. 270(6). 2764–2769. 30 indexed citations
20.
Hernández‐Sánchez, Catalina, Vicky A. Blakesley, Thea Kalebic, Lee J. Helman, & Derek LeRoith. (1995). The Role of the Tyrosine Kinase Domain of the Insulin-like Growth Factor-I Receptor in Intracellular Signaling, Cellular Proliferation, and Tumorigenesis. Journal of Biological Chemistry. 270(49). 29176–29181. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Mancini Breakdown of academic impact, for papers by L. Morgan Breakdown of academic impact, for papers by A. Traish Breakdown of academic impact, for papers by J.H.H. Thijssen Breakdown of academic impact, for papers by Léonello Cusan Breakdown of academic impact, for papers by José‐Luis Gomez Breakdown of academic impact, for papers by Fuquan Wu Breakdown of academic impact, for papers by J Gustafsson Breakdown of academic impact, for papers by Giorgio Napolitano
Rankless by CCL
2026